PubMed=22207316; DOI=10.1007/s00262-011-1179-z; PMCID=PMC3401505
Mazzarella T., Cambiaghi V., Rizzo N., Pilla L., Parolini D., Orsenigo E., Colucci A., Modorati G., Doglioni C., Parmiani G., Maccalli C.
Ex vivo enrichment of circulating anti-tumor T cells from both cutaneous and ocular melanoma patients: clinical implications for adoptive cell transfer therapy.
Cancer Immunol. Immunother. 61:1169-1182(2012)

PubMed=23849826; DOI=10.1016/j.ejca.2013.06.011
Amaro A., Mirisola V., Angelini G., Musso A., Tosetti F.I., Esposito A.I., Perri P., Lanza F.B., Nasciuti F., Mosci C., Puzone R., Salvi S., Truini M., Poggi A., Pfeffer U.
Evidence of epidermal growth factor receptor expression in uveal melanoma: inhibition of epidermal growth factor-mediated signalling by gefitinib and cetuximab triggered antibody-dependent cellular cytotoxicity.
Eur. J. Cancer 49:3353-3365(2013)